Heme-Mediated Danger Signaling Suppresses Osteogenesis Through TLR4-Dependent Inhibition of β-Catenin Signaling
- 1Department of Dentistry, Orthodontics and Craniofacial Biology, Research Institute for Medical Innovation, Radboud University Medical Center, 6525 EX Nijmegen, The Netherlands
- 2Department of Rheumatology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
Abstract
Extracellular heme is a damage-associated molecular pattern (DAMP) released during hemolysis, hemorrhage, and tissue injury. Although its pro-inflammatory and cytotoxic effects are well established, its impact on osteoblast differentiation and bone formation remains incompletely understood. Here, we investigated the effects of extracellular heme on osteoblast differentiation and defined the signaling pathways involved. In MC3T3-E1 pre-osteoblasts, heme suppressed alkaline phosphatase (ALP) activity, calcium deposition, matrix mineralization, and expression of osteogenic markers, including Runx2 and Sp7 at day 3, Col1a1 and Alpl at day 7, and Bsp and Bglap at day 10, without affecting cell viability. Mechanistically, heme reduced AKT phosphorylation and inhibitory phosphorylation of glycogen synthase kinase-3β (GSK-3β) at Ser9, consistent with increased GSK-3β activity. This was accompanied by decreased accumulation of transcriptionally active β-catenin, impaired nuclear β-catenin localization, and suppression of canonical Wnt target genes (Axin2, Lef1, Ccnd1, c-Myc). Pharmacological inhibition of GSK-3β partially restored β-catenin signaling and osteogenic differentiation, whereas inhibition of Toll-like receptor 4 (TLR4) attenuated heme-induced suppression of the AKT/GSK-3β pathway. Combined inhibition of TLR4 and GSK-3β produced the most pronounced restoration of osteogenesis in the presence of heme. Consistent with the in vitro findings, maternal heme administration during pregnancy significantly reduced ALP activity in multiple fetal craniofacial ossification centers in vivo. Collectively, these findings demonstrate that extracellular heme suppresses osteogenesis and supports a model in which TLR4-associated dysregulation of the AKT/GSK-3β/β-catenin axis contributes to impaired osteogenic differentiation.
Related
- The Cx43/p38 MAPK/Runx2 signaling pathway as a potential regulatory axis in insufficient osteogenesis associated with osteoporosis
- Dietary Leucine Restriction Suppresses Platelet-Driven HCC Growth by Attenuating mTOR Signaling.
- Ononin suppresses proliferation and glycolysis in hepatocellular carcinoma via the EGFR/PI3K/AKT signaling pathway
- Sphingolipid-Driven Lipotoxicity Promotes Calcific Aortic Valve Disease Through ER-Stress-NF-κB-EndMT Signaling and Is Therapeutically Targetable Through Serine Palmitoyltransferase Inhibition
- SD-2102, a Novel PDK1 Inhibitor, Suppresses Lung Cancer Growth by Targeting PDK1/Akt Signaling Pathway
BibTeX
@article{xiang2026hememediated,
title = {{Heme-Mediated Danger Signaling Suppresses Osteogenesis Through TLR4-Dependent Inhibition of β-Catenin Signaling}},
author = {Xiaosong Xiang and Christiaan M. Suttorp and Peng Wang and Edwin M. Ongkosuwito and Marjon Bloemen and Johannes W. Von den Hoff and Frank A. D. T. G. Wagener},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27209305},
url = {https://www.mdpi.com/1422-0067/27/20/9305},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Heme-Mediated Danger Signaling Suppresses Osteogenesis Through TLR4-Dependent Inhibition of β-Catenin Signaling
AU - Xiaosong Xiang
AU - Christiaan M. Suttorp
AU - Peng Wang
AU - Edwin M. Ongkosuwito
AU - Marjon Bloemen
AU - Johannes W. Von den Hoff
AU - Frank A. D. T. G. Wagener
PY - 2026
DA - 2026/10/01
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27209305
UR - https://www.mdpi.com/1422-0067/27/20/9305
AB - Extracellular heme is a damage-associated molecular pattern (DAMP) released during hemolysis, hemorrhage, and tissue injury. Although its pro-inflammatory and cytotoxic effects are well established, its impact on osteoblast differentiation and bone formation remains incompletely understood. Here, we investigated the effects of extracellular heme on osteoblast differentiation and defined the signaling pathways involved. In MC3T3-E1 pre-osteoblasts, heme suppressed alkaline phosphatase (ALP) activity, calcium deposition, matrix mineralization, and expression of osteogenic markers, including Runx2 and Sp7 at day 3, Col1a1 and Alpl at day 7, and Bsp and Bglap at day 10, without affecting cell viability. Mechanistically, heme reduced AKT phosphorylation and inhibitory phosphorylation of glycogen synthase kinase-3β (GSK-3β) at Ser9, consistent with increased GSK-3β activity. This was accompanied by decreased accumulation of transcriptionally active β-catenin, impaired nuclear β-catenin localization, and suppression of canonical Wnt target genes (Axin2, Lef1, Ccnd1, c-Myc). Pharmacological inhibition of GSK-3β partially restored β-catenin signaling and osteogenic differentiation, whereas inhibition of Toll-like receptor 4 (TLR4) attenuated heme-induced suppression of the AKT/GSK-3β pathway. Combined inhibition of TLR4 and GSK-3β produced the most pronounced restoration of osteogenesis in the presence of heme. Consistent with the in vitro findings, maternal heme administration during pregnancy significantly reduced ALP activity in multiple fetal craniofacial ossification centers in vivo. Collectively, these findings demonstrate that extracellular heme suppresses osteogenesis and supports a model in which TLR4-associated dysregulation of the AKT/GSK-3β/β-catenin axis contributes to impaired osteogenic differentiation.
SN - 1422-0067
ER -